Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression

23Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetic kidney disease is diagnosed and staged by albuminuria and estimated glomerular filtration rate. Although albuminuria has strong predictive power for renal function decline, there is still variability in the rate of renal disease progression across individuals that are not fully captured by the level of albuminuria. Therefore, research focuses on discovering and validating additional biomarkers that improve risk stratification for future renal function decline and end-stage renal disease in patients with diabetes, on top of established biomarkers. Most studies address the value of single biomarkers to predict progressive renal disease and aim to understand the mechanisms that underlie accelerated renal function decline. Since diabetic kidney disease is a disease encompassing several pathophysiological processes, a combination of biomarkers may be more likely to improve risk prediction than a single biomarker. In this review, we provide an overview of studies on the use of multiple biomarkers and biomarker panels, appraise their study design, discuss methodological pitfalls and make recommendations for future biomarker panel studies.

References Powered by Scopus

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

5345Citations
N/AReaders
Get full text

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

5325Citations
N/AReaders
Get full text

Use and misuse of the receiver operating characteristic curve in risk prediction

1722Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: A systematic literature review

67Citations
N/AReaders
Get full text

Serum kidney injury molecule 1 and β<inf>2</inf>-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes

61Citations
N/AReaders
Get full text

The Landscape of Diabetic Kidney Disease in the United States

54Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Schutte, E., Gansevoort, R. T., Benner, J., Lutgers, H. L., & Lambers Heerspink, H. J. (2015, January 12). Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression. Nephrology Dialysis Transplantation. Oxford University Press. https://doi.org/10.1093/ndt/gfv119

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

47%

Professor / Associate Prof. 7

37%

Researcher 2

11%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

65%

Biochemistry, Genetics and Molecular Bi... 4

20%

Agricultural and Biological Sciences 2

10%

Design 1

5%

Save time finding and organizing research with Mendeley

Sign up for free